SIGA Technologies
www.siga.comAt SIGA, we specialize in developing therapeutic solutions for some of the most lethal pathogens – smallpox, Ebola, dengue, Lassa fever and other dangerous viruses. Our objective is to discover, develop, and commercialize drugs to prevent and treat these high-priority threats.
Read more
At SIGA, we specialize in developing therapeutic solutions for some of the most lethal pathogens – smallpox, Ebola, dengue, Lassa fever and other dangerous viruses. Our objective is to discover, develop, and commercialize drugs to prevent and treat these high-priority threats.
Read more
Country
State
New York
City (Headquarters)
New York City
Industry
Founded
1995
Estimated Revenue
$10,000,000 to $50,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Executive Vice President and Chief Financial Officer
Email ****** @****.comPhone (***) ****-****Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Director of Business Development
Email ****** @****.comPhone (***) ****-****Director , Audit Committee Chair
Email ****** @****.comPhone (***) ****-****
Technologies
(1)
Reach decision makers at SIGA Technologies
Free credits every month!
SIGA Technologies FAQ
New York City, United States
Pharmaceutical Manufacturing
We'll help you understand if Lusha can solve your business needs.
